Free provider profile
MARTY BENNETT, MD
NPI 1487616272
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2021-04-06.
16479 DALLAS PKWY STE 320, ADDISON, TX, 75001
469-484-4260
Single practice location
Enumerated 2006-04-05
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 5 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
580
Medicare patients
69
Part D drug cost
$115,866
Brand-name share
14%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Vyvanse (Lisdexamfetamine Dimesylate) | 28 | $10,883 |
| Adderall Xr (Dextroamphetamine/Amphetamine) | 14 | $6,304 |
| Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate) | 19 | $4,697 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | 79 | $2,890 |
| Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine) | 24 | $1,611 |
| Trazodone Hcl (Trazodone Hcl) | 20 | $1,536 |
| Vilazodone Hcl (Vilazodone Hcl) | 11 | $1,256 |
| Divalproex Sodium Er (Divalproex Sodium) | 18 | $967 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024454 sessions · 24 patients · $405,888
2023282 sessions · 18 patients · $254,068
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.